Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers

被引：4
|
作者：
Yu, Yingyan [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Digest Surg, Dept Gen Surg,Sch Med,Shanghai Key Lab Gastr Neop, Shanghai 200025, Peoples R China
来源：
CANCER BIOLOGY & MEDICINE | 2021年 / 18卷 / 04期
基金：
中国国家自然科学基金;
关键词：
RESISTANCE; SURVIVAL; COVID-19; GENES;
D O I：
10.20892/j.issn.2095-3941.2021.0491
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：944 / 948
页数：5
相关论文
共 50 条
  • [21] Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers
    Li, Meng
    Kaili, Denis
    Shi, Lei
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (01) : 19 - 37
  • [22] Immune checkpoint inhibitors in patients with cancers of unknown primary
    Rassy, Elie
    Karam, Elias
    Adeleke, Sola
    Okoli, Somto
    Galante, Joao
    Boussios, Stergios
    Pavlidis, Nicholas
    EUROPEAN JOURNAL OF CANCER, 2023, 195
  • [23] Current Status of Immune Checkpoint Inhibitors in Gastrointestinal Cancers
    Kim, Bum Jun
    Jang, Hyun Joo
    Kim, Hyeong Su
    Kim, Jung Han
    JOURNAL OF CANCER, 2017, 8 (08): : 1460 - 1465
  • [24] COVID-19 vaccines in patients with solid tumor cancers receiving immune checkpoint inhibitors
    Gilbert, Danielle
    Hu, Junxiao
    Lam, Elaine T.
    CANCER RESEARCH, 2023, 83 (07)
  • [25] Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis
    Takenaka, Yukinori
    Oya, Ryohei
    Takemoto, Norihiko
    Inohara, Hidenori
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (05) : 1122 - 1135
  • [26] Biomarkers for immune checkpoint inhibitors in solid tumors
    Kapoor, Vidit
    Kelly, William James
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 126 - 136
  • [27] Biomarkers for immune checkpoint inhibitors in solid tumors
    Vidit Kapoor
    William James Kelly
    Clinical and Translational Oncology, 2023, 25 : 126 - 136
  • [28] Glucocorticoids before immune checkpoint inhibitors: more enemy than friendGlucocorticoids before immune checkpoint inhibitors: more enemy than friend
    Karitzky, P. C.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 44 - 45
  • [29] Adjuvant therapy for mucosal melanoma in the era of immune checkpoint inhibitors
    Nakamura, Yasuhiro
    Mori, Tatsuhiko
    CHINESE CLINICAL ONCOLOGY, 2024, 13 (01)
  • [30] Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting
    Herrscher, Hugo
    Robert, Caroline
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (02) : 106 - 113
12345